BioCentury
ARTICLE | Financial News

Innovent raises $150M series E

April 27, 2018 7:55 PM UTC

Innovent Biologics Inc. (Suzhou, China) raised $150 million in a series E round. Lead investor Capital Group Private Markets committed $90 million in the round, and its partner Nick Chen joined Innovent’s board.

New investors Cormorant Asset Management, Rock Springs Capital and Ally Bridge Group joined existing investors Temasek, Hillhouse, Legend Capital, Lilly Asia Venture and Taikang Insurance in the round...

BCIQ Company Profiles

Innovent Biologics Inc.